Oxycontin (Oxycodone HCl) Patent Expiration, LOE Window & CMS Spending

Oxycontin (Oxycodone HCl) by Knoa: FDA Orange Book LOE 2030-03-29, 14 AB generics, $397.4M 2024 CMS Part D & Medicaid spend, and 42 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorKnoa
FDA Application & PathwayN022272 (NDA)
Exclusivity / Cliff HorizonNear-Term Cliff (2028-2030)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2030-03-29
Orange Book Patents (*PED Extensions)15 patents (0 *PED)
Active AB-Rated Generic Competitors14
2024 CMS Total Public Spend$397.4M
2024 Medicare Part D Spend$337.8M
2024 Medicaid Spend$59.6M
Reported Wholesale Price Change (CA SB 17)42 WAC filings (max 25.7% 2-yr change)